Project summary

MetFlex is an investigator initiated and conducted, multicentre, international, open-label, single-arm, Phase 2a trial to determine the safety and tolerability of trimetazidine for the treatment of amyotrophic lateral sclerosis/motor neuron disease (ALS/MND).






Project members

A/Prof Shyuan Ngo

Group Leader
Ngo Group

Sally Allen

Ngo Group

Angela Schmidt

Clinical Research Nurse
Ngo Group